INDP - Indaptus Therapeutics, Inc.
1.85
-0.050 -2.703%
Share volume: 29,825
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.05
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-12-2024 | 11-12-2024 | 03-13-2025 | 05-14-2025 | 11-12-2025 | |
| Assets | |||||||
| Total Assets | 10.949 M | 8.122 M | 8.240 M | 7.339 M | 5.412 M | 6.840 M | |
| Current Assets | 10.293 M | 7.488 M | 7.629 M | 6.618 M | 4.961 M | 6.439 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.742 M | 7.302 M | 7.381 M | 5.787 M | 3.891 M | 5.826 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 655.846 K | 633.358 K | 610.383 K | 720.426 K | 450.691 K | 401.059 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 10.949 M | 8.122 M | 8.240 M | 7.339 M | 5.412 M | 6.840 M | |
| Total liabilities | 1.588 M | 1.956 M | 2.236 M | 3.394 M | 2.612 M | 2.234 M | |
| Total current liabilities | 1.537 M | 1.928 M | 2.232 M | 3.394 M | 2.612 M | 2.234 M | |
| Accounts Payable | 1.435 M | 1.825 M | 2.128 M | 3.310 M | 2.552 M | 2.226 M | |
| Other liabilities | 50.664 K | 27.579 K | 4.007 K | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 50.664 K | 27.579 K | 4.007 K | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.361 M | 6.166 M | 6.003 M | 3.945 M | 2.800 M | 4.606 M | |
| Common stock | 58.584 M | 59.405 M | 62.311 M | 64.384 M | 67.771 M | 77.781 M | |
| Retained earnings | -49.224 M | -53.239 M | -56.308 M | -60.439 M | -64.972 M | -73.176 M |